Skip to content

Cerebral Oximetry in Cardiac Surgery to Reduce Neurological Impairment and Hospital Length-of-stay

Cerebral Oximetry in Adult Cardiac Surgery to Reduce the Incidence of Neurological Impairment and Hospital Length-of-stay: A Prospective, Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04463563
Enrollment
182
Registered
2020-07-09
Start date
2011-02-01
Completion date
2014-09-01
Last updated
2020-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Cerebral Ischemia, Neural Injury

Brief summary

Cerebral oximetry using near-infrared spectroscopy (NIRS) has been shown to reduce the incidence of neurological dysfunction and hospital length-of-stay in adult cardiac surgery though not all studies agree. A previous audit using cerebral saturations at or above baseline showed improved neurological and length-of-stay outcomes.

Detailed description

This prospective, single centre, double-blinded controlled study randomized 182 consecutive patients, scheduled for cardiac surgical procedures using cardiopulmonary bypass. Participants were randomized by concealed envelope prior to anaesthesia. NIRS study group were managed perioperatively using our NIRS protocol. The control group had standard management without NIRS. Primary outcomes were post-operative neurological impairment and hospital length-of-stay. Secondary outcomes included ventilation times, intensive care unit length-of-stay, major organ dysfunction and mortality

Interventions

Changes to carbon dioxide, oxygen flow, cardiac output, blood pressure, haemoglobin, surgical surveillance, depth of anaesthesia, patient position.

Sponsors

The Hull and East Riding Cardiac Trust Fund
CollaboratorUNKNOWN
Hull University Teaching Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The personnel assessing and collecting the post-operative data were unaware of the patient group in the operating room.

Intervention model description

This prospective, single centre, double-blinded controlled study randomized 182 consecutive patients, scheduled for cardiac surgical procedures using cardiopulmonary bypass. Participants were randomized by concealed envelope.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients undergoing elective cardiac surgery using cardiopulmonary bypass. Patient over 18 years age. -

Exclusion criteria

Emergency surgery. Cardiac surgery without cardiopulmonary bypass. Inability to perform test. Persistent neurological conditions: Recent stroke. Dementia. Alzheimer's Disease Parkinson's Disease \-

Design outcomes

Primary

MeasureTime frameDescription
Late neurocognitive test 36 months post opFunctionality questions were: Stairs, driving, cleaning, dressing, eating/cooking.
Neurocognitive test 5Day 3 post opGeneral well-being HADS (hospital anxiety and depression score) A and D. HADS A -hospital anxiety and depression score relating to Anxiety. HADS D- hospital anxiety and depression score relating to Depression. Patients are asked a question and their response is scored from 0-3. There are 14 questions the score is recorded and compared with the score after the same questions on the 3rd post-op day. The result gives an indication of the patient's mental state and how it may have changed dur to the sugery.
Late neurocognitive test 1.Telephone questionnaire using elements of the previously used questionnaires.6 months post opGeneral health questions were: how is your overall health, memory, mood, motor function?Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.
Late neurocognitive test 2. Telephone questionnaire using elements of the previously used questionnaires.6 months post opCognition questions were: Date, repeat and recall, serial 7s, spell, recall. Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.
Hospital length-of-stayMeasured in days from the day of operation to the day the patient is discharged from hospital or death in hospital. If neither has occurred within 6 months of participant's operation it will be recorded as 6 months hospital stay.How long before discharge post-operatively.
Physical neurological examination3 day post-operativelyMobility and conscious control of limbs.
Neurological assessment.6 months post-operativelyTelephone interview to assess patients perception of mobility, function and well being. (see below details)
Neurocognitive test 1Day 3 post op.Fluency and cognitive functions: Mini-Mental State Examination (MMSE). This test is conducted as a questionnaire of 11 questions. Questions include 'what is the date?', 'name the town you are in?', spelling-forwards and backwards, counting backwards, copying a picture, follow an instruction, naming objects etc. The test is scored out of 30 and recorded in a table. The test is repeated on the third post op day and the 2 scores compared to give a number which relates to performance.
Neurocognitive Test 2Day 3 post opVisual attention and task switching: Trail Making test A and B
Neurocognitive test 3Day 3 post opVisual-spatial, frontal lobe: Anti-saccadic eye test
Neurocognitive test 4Day 3 post opExecutive function/verbal immediate and delayed recall: Hopkins Verbal and Hopkins Delay.

Secondary

MeasureTime frameDescription
Major organ dysfunctionBefore hospital dischargeRenal function is assessed measuring creatinine. Gastrointestinal function is assessed by the diagnosis of ileus or ischaemic bowel at laparotomy. Cardiac function is assessed by the requirement for inotropic support. Respiratory function is assessed by the requirement for ventilation. All these outcomes are have clinical relevance during the stay on ICU.
MortalityDay of surgery to death. If the participant is discharged from hospital alive it is not a mortality. Assessed for 6 months from the day of surgery.Death in hospital at any time following surgery. Death is considered a mortality.
Intensive Care length-of-stayThe assessment period is every day on ICU until participant moved to ward. Or patient dies on ICU. Total assessment period 6 months.Days on ICU. The time from the day of surgery to the discharge to the ward or death. assessed .

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026